{"title":"Telehealth has comparable outcomes to in-person diabetic foot care during the COVID-19 pandemic.","authors":"Nikolaos Kamaratos-Sevdalis, Alexandros Kamaratos, Marios Papadakis, Christos Tsagkaris","doi":"10.5662/wjm.v12.i4.285","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The coronavirus disease 2019 (COVID-19) pandemic has posed obstacles to the delivery of diabetic foot care. In response to this remote healthcare services have been deployed offering monitoring, follow-up, and referral services to patients with diabetic foot ulcers and related conditions. Although, remote diabetic foot care has been studied before the COVID-19 pandemic as an alternative to in-person care, the peculiar situation of the pandemic, which dictates that remote care would be the sole available option for healthcare practitioners and patients, necessitates an evaluation of the relevant knowledge obtained since the beginning of the severe acute respiratory syndrome coronavirus 2 outbreak.</p><p><strong>Aim: </strong>To perform a thorough search in PubMed/Medline and Cochrane to identify original records on the topic.</p><p><strong>Methods: </strong>To identify relevant peer-reviewed publications and gray literature, the authors searched PubMed-MEDLINE and Cochrane Library-Cochrane Central Register of Controlled Trials starting September 27 till October 31, 2021. The reference lists of the selected sources and relevant systematic reviews were also hand-searched to identify potentially relevant resources. Otherwise, the authors searched <i>Reference Citation Analysis</i> (https://www.referencecitationanalysis.com/).</p><p><strong>Results: </strong>A number of randomized prospective studies, case series, and case reports have shown that the effectiveness of remote care is comparable to in-person care in terms of hospitalizations, amputations, and mortality. The level of satisfaction of patients' receiving this type of care was high. The cost of remote healthcare was not significantly lower than in - person care though.</p><p><strong>Conclusion: </strong>It is noteworthy that remote care during the COVID-19 pandemic appeared to be more effective and well - received than remote care in the past. Nevertheless, larger studies spanning over longer time intervals are necessary in order to validate these results and provide additional insights.</p>","PeriodicalId":23729,"journal":{"name":"World journal of methodology","volume":"12 4","pages":"285-292"},"PeriodicalIF":0.0000,"publicationDate":"2022-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/54/c7/WJM-12-285.PMC9350733.pdf","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World journal of methodology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5662/wjm.v12.i4.285","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2
Abstract
Background: The coronavirus disease 2019 (COVID-19) pandemic has posed obstacles to the delivery of diabetic foot care. In response to this remote healthcare services have been deployed offering monitoring, follow-up, and referral services to patients with diabetic foot ulcers and related conditions. Although, remote diabetic foot care has been studied before the COVID-19 pandemic as an alternative to in-person care, the peculiar situation of the pandemic, which dictates that remote care would be the sole available option for healthcare practitioners and patients, necessitates an evaluation of the relevant knowledge obtained since the beginning of the severe acute respiratory syndrome coronavirus 2 outbreak.
Aim: To perform a thorough search in PubMed/Medline and Cochrane to identify original records on the topic.
Methods: To identify relevant peer-reviewed publications and gray literature, the authors searched PubMed-MEDLINE and Cochrane Library-Cochrane Central Register of Controlled Trials starting September 27 till October 31, 2021. The reference lists of the selected sources and relevant systematic reviews were also hand-searched to identify potentially relevant resources. Otherwise, the authors searched Reference Citation Analysis (https://www.referencecitationanalysis.com/).
Results: A number of randomized prospective studies, case series, and case reports have shown that the effectiveness of remote care is comparable to in-person care in terms of hospitalizations, amputations, and mortality. The level of satisfaction of patients' receiving this type of care was high. The cost of remote healthcare was not significantly lower than in - person care though.
Conclusion: It is noteworthy that remote care during the COVID-19 pandemic appeared to be more effective and well - received than remote care in the past. Nevertheless, larger studies spanning over longer time intervals are necessary in order to validate these results and provide additional insights.
背景:2019冠状病毒病(COVID-19)大流行给糖尿病足护理的提供带来了障碍。针对这种情况,已经部署了远程医疗服务,为糖尿病足溃疡和相关病症患者提供监测、随访和转诊服务。尽管在COVID-19大流行之前就已经研究过远程糖尿病足护理作为面对面护理的替代方案,但大流行的特殊情况决定了远程护理将是医护人员和患者的唯一可用选择,因此有必要对自严重急性呼吸综合征冠状病毒2爆发以来获得的相关知识进行评估。目的:在PubMed/Medline和Cochrane中进行彻底的搜索,以确定有关该主题的原始记录。方法:作者检索PubMed-MEDLINE和Cochrane Library-Cochrane Central Register of Controlled Trials,检索时间为2021年9月27日至10月31日。还手工检索了选定来源的参考文献清单和相关的系统综述,以确定潜在的相关资源。此外,作者检索了参考引文分析(https://www.referencecitationanalysis.com/).Results:)。大量随机前瞻性研究、病例系列和病例报告表明,在住院、截肢和死亡率方面,远程护理的有效性与现场护理相当。患者对此类护理的满意度较高。然而,远程医疗的成本并不明显低于现场医疗。结论:2019冠状病毒病疫情期间的远程医疗比以往的远程医疗更有效、更受欢迎。然而,为了验证这些结果并提供额外的见解,需要在更长的时间间隔内进行更大规模的研究。